GlassScriptPhysician profile
Tyson K Cobb
NPI 1598735094
$154,647.02
in general payments reported to CMS, 2019-2025
11 companies · $12K in 2025
The $12K reported for 2025 was more than what 93% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $20K · 2021: $8,595 · 2022: $44K · 2023: $19K · 2024: $20K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $50K · Travel and Lodging: $560 · Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $49,523.89 |
| Travel and Lodging | $559.70 |
| Food and Beverage | $471.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $93,956.66 | 2022-2025 | Endorelease Cubital Tunnel System |
| Integra Lifesciences Corporation | $59,524.51 | 2019-2021 | |
| Prism Medical | $680.15 | 2024 | |
| Arthrex, INC. | $250.00 | 2024 | |
| Aesculap, INC. | $99.58 | 2021 | |
| Mauna Kea Technologies, INC. | $37.81 | 2021-2024 | |
| Stryker Corporation | $33.38 | 2023 | Variax |
| Wardlow Enterprises | $23.69 | 2023 | |
| Orthofix Medical, INC. | $21.28 | 2019 | |
| Pfizer INC. | $19.96 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$38,530.08 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyson Cobb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.